| Literature DB >> 28541042 |
Masahiro Okada1, Kai Saito1, Chin Piow Wong1, Chang Li1, Dongmei Wang1, Miu Iijima2, Futoshi Taura2, Fumiya Kurosaki2, Takayoshi Awakawa1, Ikuro Abe1.
Abstract
Daurichromenic acid is a meroterpenoid with various pharmacological activities that is biosynthesized from grifolic acid in Rhododendron dauricum. Heterologous expression of grifolic acid synthases from Stachybotrys bisbyi and a daurichromenic acid synthase from R. dauricum in Aspergillus oryzae mediated three-step combinatorial biosynthesis of (+)-daurichromenic acid through enantioselective 6-endo-trig cyclization. Additional introduction of a halogenase from Fusarium sp. into the strain resulted in the biosynthesis of (+)-5-chlorodaurichromenic acid, which exceeds the antibacterial activity of the original compounds.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28541042 DOI: 10.1021/acs.orglett.7b01288
Source DB: PubMed Journal: Org Lett ISSN: 1523-7052 Impact factor: 6.005